$KPTI
Karyopharm Therapeutics Inc.

2022 Q1 Form 10-K Financial Statement

#000095017022002548 Filed on March 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 2020 Q4
Revenue $47.67M $209.8M $35.10M
YoY Change 104.94% 94.12% 93.92%
Cost Of Revenue $1.426M $3.402M $1.050M
YoY Change 53.33% 26.0% -24.46%
Gross Profit $46.24M $206.4M $34.05M
YoY Change 107.09% 95.84% 103.89%
Gross Profit Margin 97.01% 98.38% 97.01%
Selling, General & Admin $38.77M $143.8M $33.93M
YoY Change 2.97% 13.79% 19.51%
% of Gross Profit 83.83% 69.69% 99.65%
Research & Development $42.06M $160.8M $37.19M
YoY Change 13.53% 6.65% 17.76%
% of Gross Profit 90.96% 77.92% 109.22%
Depreciation & Amortization $177.0K $800.0K $250.0K
YoY Change -24.68% -20.0% 4.17%
% of Gross Profit 0.38% 0.39% 0.73%
Operating Expenses $82.26M $308.1M $71.12M
YoY Change 8.76% 10.06% 18.59%
Operating Profit -$34.59M -$98.27M -$37.07M
YoY Change -33.96% -42.82% -14.33%
Interest Expense $6.684M $26.05M -$6.680M
YoY Change 31.19% -4.03% 24.39%
% of Operating Profit
Other Income/Expense, Net -$6.683M -$25.55M $380.0K
YoY Change 36.61% 5.95% -3900.0%
Pretax Income -$41.27M -$123.8M -$43.36M
YoY Change -27.93% -36.81% -10.87%
Income Tax $130.0K $300.0K $60.00K
% Of Pretax Income
Net Earnings -$41.40M -$124.1M -$43.42M
YoY Change -27.89% -36.78% -10.75%
Net Earnings / Revenue -86.84% -59.14% -123.7%
Basic Earnings Per Share -$0.53 -$1.65
Diluted Earnings Per Share -$533.7K -$1.650M -$588.8K
COMMON SHARES
Basic Shares Outstanding 79.16M 75.22M
Diluted Shares Outstanding 77.57M 75.22M

Balance Sheet

Concept 2022 Q1 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $205.3M $228.6M $249.2M
YoY Change -8.49% -8.26% -4.85%
Cash & Equivalents $153.3M $190.5M $85.92M
Short-Term Investments $52.06M $38.16M $163.3M
Other Short-Term Assets $29.14M $20.39M $11.80M
YoY Change 185.64% 72.78% 40.48%
Inventory $3.874M $4.106M $2.644M
Prepaid Expenses $12.21M
Receivables $24.99M $22.50M $12.90M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $276.5M $275.6M $276.5M
YoY Change 8.23% -0.32% -0.73%
LONG-TERM ASSETS
Property, Plant & Equipment $1.544M $9.557M $2.219M
YoY Change -22.18% -17.61% -27.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $24.20M
YoY Change -100.0% 1110.0%
Other Assets $8.438M $20.14M $700.0K
YoY Change 1105.43% 2777.43% 0.0%
Total Long-Term Assets $17.50M $29.70M $36.52M
YoY Change -9.78% -18.86% 122.77%
TOTAL ASSETS
Total Short-Term Assets $276.5M $275.6M $276.5M
Total Long-Term Assets $17.50M $29.70M $36.52M
Total Assets $294.0M $305.3M $313.1M
YoY Change 6.96% -2.49% 6.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.440M $1.603M $4.450M
YoY Change 13.16% -64.38% 351.78%
Accrued Expenses $58.37M $71.44M $52.93M
YoY Change 4.96% 30.36% 29.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $66.34M $73.72M $60.20M
YoY Change 6.98% 22.46% 29.89%
LONG-TERM LIABILITIES
Long-Term Debt $302.5M $302.3M $191.0M
YoY Change 25.1% 58.27% 4.14%
Other Long-Term Liabilities $8.286M $8.969M $11.30M
YoY Change -22.56% -20.63% -26.62%
Total Long-Term Liabilities $310.8M $311.3M $202.3M
YoY Change 23.08% 53.86% 1.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $66.34M $73.72M $60.20M
Total Long-Term Liabilities $310.8M $311.3M $202.3M
Total Liabilities $377.1M $385.0M $262.5M
YoY Change 19.89% 46.66% 7.06%
SHAREHOLDERS EQUITY
Retained Earnings -$1.220B -$1.070B
YoY Change 9.72% 22.47%
Common Stock $1.137B $1.120B
YoY Change 6.05% 21.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$83.08M -$79.67M $50.55M
YoY Change
Total Liabilities & Shareholders Equity $294.0M $305.3M $313.1M
YoY Change 6.96% -2.49% 6.13%

Cashflow Statement

Concept 2022 Q1 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$41.40M -$124.1M -$43.42M
YoY Change -27.89% -36.78% -10.75%
Depreciation, Depletion And Amortization $177.0K $800.0K $250.0K
YoY Change -24.68% -20.0% 4.17%
Cash From Operating Activities -$59.20M -$107.1M -$30.63M
YoY Change 11.93% -33.15% -22.44%
INVESTING ACTIVITIES
Capital Expenditures $79.00K $212.0K -$120.0K
YoY Change 46.21% 140.0%
Acquisitions
YoY Change
Other Investing Activities -$13.96M $142.1M $31.52M
YoY Change -132.31% -365.32% -194.17%
Cash From Investing Activities -$14.04M $141.8M $31.39M
YoY Change -132.5% -364.21% -193.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.78M 73.65M 3.960M
YoY Change 188.34% -57.2% -88.67%
NET CHANGE
Cash From Operating Activities -59.20M -107.1M -30.63M
Cash From Investing Activities -14.04M 141.8M 31.39M
Cash From Financing Activities 30.78M 73.65M 3.960M
Net Change In Cash -42.54M 108.3M 4.720M
YoY Change -4917.55% -360.59% -112.4%
FREE CASH FLOW
Cash From Operating Activities -$59.20M -$107.1M -$30.63M
Capital Expenditures $79.00K $212.0K -$120.0K
Free Cash Flow -$59.28M -$107.3M -$30.51M
YoY Change 12.08% -33.08% -22.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3931704
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
85 Wells Avenue, 2nd Floor
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
CY2019 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Newton
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02459
CY2021 dei City Area Code
CityAreaCode
617
CY2019 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
CY2019 us-gaap Payments For Royalties
PaymentsForRoyalties
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001503802
CY2019 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
CY2019 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
CY2020Q4 us-gaap Other Assets
OtherAssets
CY2020 kpti Proceeds From Amended Revenue Interest Agreement
ProceedsFromAmendedRevenueInterestAgreement
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-36167
CY2021 dei Entity Registrant Name
EntityRegistrantName
KARYOPHARM THERAPEUTICS INC.
CY2021 dei Local Phone Number
LocalPhoneNumber
658-0600
CY2021 dei Security12b Title
Security12bTitle
Common Stock
CY2021 dei Trading Symbol
TradingSymbol
KPTI
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2219000
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
738500000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79160016
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190459000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85918000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
38156000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
163322000
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
22497000
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
12881000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4106000
CY2020Q4 us-gaap Inventory Net
InventoryNet
2644000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14039000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9285000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
6349000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2481000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
275606000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
276531000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1642000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7915000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9363000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
24215000
CY2021Q4 us-gaap Other Assets
OtherAssets
19505000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
637000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
722000
CY2021Q4 us-gaap Assets
Assets
305305000
CY2020Q4 us-gaap Assets
Assets
313050000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1603000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4450000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
69121000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52930000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
297000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2316000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1917000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
678000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
609000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
73718000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60203000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
169293000
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
117928000
CY2021Q4 kpti Deferred Royalty Obligation Noncurrent
DeferredRoyaltyObligationNoncurrent
132998000
CY2020Q4 kpti Deferred Royalty Obligation Noncurrent
DeferredRoyaltyObligationNoncurrent
73088000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8969000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11285000
CY2021Q4 us-gaap Liabilities
Liabilities
384978000
CY2020Q4 us-gaap Liabilities
Liabilities
262504000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75746000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75746000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73923000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73923000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1098776000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1119632000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
191000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
518000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1178648000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1069611000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-79673000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
50546000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
305305000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
313050000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
209819000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108085000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40893000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
122340000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
143846000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
126417000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105421000
CY2021 us-gaap Operating Expenses
OperatingExpenses
308090000
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3402000
CY2020 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2705000
CY2019 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2407000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
160842000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
150813000
CY2020 us-gaap Operating Expenses
OperatingExpenses
279935000
CY2019 us-gaap Operating Expenses
OperatingExpenses
230168000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-98271000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-171850000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-189275000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
582000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
2820000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
5422000
CY2021 us-gaap Interest Expense
InterestExpense
26046000
CY2020 us-gaap Interest Expense
InterestExpense
27140000
CY2019 us-gaap Interest Expense
InterestExpense
15647000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-85000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
206000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-50000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25549000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-24114000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10275000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-123820000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-195964000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-199550000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
268000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-124088000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-196273000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-199590000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.65
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.72
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.22
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
75218000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72044000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61955000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-124088000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-196273000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-199590000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-286000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
288000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
207000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-41000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7862000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
267000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-124415000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-195718000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-199383000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
183170000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4505000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15291000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46191000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
207000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-199590000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
49774000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10307000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24407000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
161776000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
288000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
267000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-196273000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
50546000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3745000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29783000
CY2021 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
1355000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9903000
CY2021 kpti Cumulative Effect Adjustment For Adoption Of New Accounting Guidance
CumulativeEffectAdjustmentForAdoptionOfNewAccountingGuidance
-50590000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-286000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-41000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-124088000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-79673000
CY2021 us-gaap Profit Loss
ProfitLoss
-124088000
CY2020 us-gaap Profit Loss
ProfitLoss
-196273000
CY2019 us-gaap Profit Loss
ProfitLoss
-199590000
CY2021 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
7355000
CY2021 us-gaap Depreciation
Depreciation
789000
CY2020 us-gaap Depreciation
Depreciation
972000
CY2019 us-gaap Depreciation
Depreciation
974000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1560000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1419000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1382000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
780000
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8071000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7193000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
29783000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
24407000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
15291000
CY2021 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
16000
CY2020 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
15000
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
329000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9616000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5019000
CY2021 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
90000
CY2020 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
500000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1462000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2627000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
346000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5254000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1996000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
868000
CY2021 kpti Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1449000
CY2020 kpti Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1254000
CY2019 kpti Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1094000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
19505000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2847000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3465000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3301000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
16260000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
12161000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
8512000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-297000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4236000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-9362000
CY2021 kpti Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1917000
CY2020 kpti Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1646000
CY2019 kpti Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1175000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-107116000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-160234000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-190822000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
212000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
145000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
206000
CY2021 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
192780000
CY2020 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
221037000
CY2019 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
257145000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
45228000
CY2020 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
274577000
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
178489000
CY2021 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
5500000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
141840000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53685000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
78450000
CY2021 kpti Proceeds From Payments For Common Stock Issuance Net
ProceedsFromPaymentsForCommonStockIssuanceNet
9903000
CY2020 kpti Proceeds From Payments For Common Stock Issuance Net
ProceedsFromPaymentsForCommonStockIssuanceNet
161776000
CY2019 kpti Proceeds From Payments For Common Stock Issuance Net
ProceedsFromPaymentsForCommonStockIssuanceNet
46191000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3745000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10307000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4505000
CY2021 kpti Proceeds From Amended Revenue Interest Agreement
ProceedsFromAmendedRevenueInterestAgreement
60000000
CY2019 kpti Proceeds From Amended Revenue Interest Agreement
ProceedsFromAmendedRevenueInterestAgreement
73609000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
73648000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
172083000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
124305000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-48000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197445000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89121000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130689000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190459000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85918000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
108324000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41568000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11952000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89121000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130689000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118737000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
128858000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
6349000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2481000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1117000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
637000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
722000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
714000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197445000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89121000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130689000
CY2021 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
5175000
CY2020 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
5175000
CY2019 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
5175000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11711000
CY2021 kpti Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
3277000
CY2020 kpti Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
3200000
CY2019 kpti Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
2889000
CY2021 us-gaap Payments For Royalties
PaymentsForRoyalties
10361000
CY2020 us-gaap Payments For Royalties
PaymentsForRoyalties
6014000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1200000000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On an ongoing basis, we evaluate our estimates, including estimates related to our net product revenue, license revenue, clinical trial accruals, stock-based compensation expense, interest expense on our deferred royalty obligation, valuation allowances, migration of intellectual property to the United States, and other reported amounts of expenses during the reported period. We base our estimates on historical experience and other market-specific or relevant assumptions that we believe to be reasonable under the circumstances. Although we regularly assess these estimates, actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known.</span></p>
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
95101000
CY2021Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
3080000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
218877000
CY2020Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
1800000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2219000
CY2021 us-gaap Depreciation
Depreciation
800000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7699000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7407000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6057000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5188000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1642000
CY2020 us-gaap Depreciation
Depreciation
1000000.0
CY2019 us-gaap Depreciation
Depreciation
1000000.0
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
187256000
CY2020 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
327000
CY2020 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
46000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
187537000
CY2021Q4 kpti Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Years
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYears
10
CY2020Q4 kpti Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Years
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYears
37
CY2021Q4 kpti Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Other Than Temporary Impairments
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxOtherThanTemporaryImpairments
0
CY2020Q4 kpti Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Other Than Temporary Impairments
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxOtherThanTemporaryImpairments
0
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
26650000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
9000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
26650000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
9000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
88480000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
46000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
88480000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
46000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1797000
CY2020Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1919000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1895000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
646000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
414000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
79000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4106000
CY2020Q4 us-gaap Inventory Net
InventoryNet
2644000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
21978000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
12250000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19687000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16214000
CY2021Q4 kpti Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
15894000
CY2020Q4 kpti Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
15087000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5961000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5229000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5601000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4150000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
69121000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52930000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
2800000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
2800000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
2800000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3447000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3718000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3817000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2918000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13900000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2615000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11285000
CY2021Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y9M18D
CY2021Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.11
kpti Revenue Recognition Provision For Discounts And Charge Backs
RevenueRecognitionProvisionForDiscountsAndChargeBacks
2657000
kpti Revenue Recognition Provision For Fees Rebates And Other Incentives
RevenueRecognitionProvisionForFeesRebatesAndOtherIncentives
2318000
kpti Revenue Recognition Sale Returns Reserve For Sale Returns
RevenueRecognitionSaleReturnsReserveForSaleReturns
234000
kpti Revenue Recognition Provision For Discounts Charge Backs Fees Rebates Other Incentives And Sales Returns
RevenueRecognitionProvisionForDiscountsChargeBacksFeesRebatesOtherIncentivesAndSalesReturns
5209000
kpti Revenue Recognition Payments For Charge Backs
RevenueRecognitionPaymentsForChargeBacks
-1655000
kpti Revenue Recognition Payments For Fees Rebates And Other Incentives
RevenueRecognitionPaymentsForFeesRebatesAndOtherIncentives
-499000
kpti Revenue Recognition Credits For Discounts Charge Backs Fees Rebates Other Incentives And Sales Returns Current Year
RevenueRecognitionCreditsForDiscountsChargeBacksFeesRebatesOtherIncentivesAndSalesReturnsCurrentYear
-2154000
CY2019Q4 kpti Revenue Recognition Discounts And Charge Backs
RevenueRecognitionDiscountsAndChargeBacks
1002000
CY2019Q4 kpti Revenue Recognition Fees Rebates And Other Incentives
RevenueRecognitionFeesRebatesAndOtherIncentives
1819000
CY2019Q4 kpti Revenue Recognition Sales Return
RevenueRecognitionSalesReturn
234000
CY2019Q4 kpti Revenue Recognition Discounts Charge Backs Fees Rebates Other Incentives And Sales Returns
RevenueRecognitionDiscountsChargeBacksFeesRebatesOtherIncentivesAndSalesReturns
3055000
CY2020 kpti Revenue Recognition Provision For Discounts And Charge Backs
RevenueRecognitionProvisionForDiscountsAndChargeBacks
9754000
CY2020 kpti Revenue Recognition Provision For Fees Rebates And Other Incentives
RevenueRecognitionProvisionForFeesRebatesAndOtherIncentives
4263000
CY2020 kpti Revenue Recognition Payments For Chargebacks Current Year
RevenueRecognitionPaymentsForChargebacksCurrentYear
-8677000
CY2020 kpti Revenue Recognition Sale Returns Reserve For Sale Returns
RevenueRecognitionSaleReturnsReserveForSaleReturns
435000
CY2020 kpti Revenue Recognition Provision For Discounts Charge Backs Fees Rebates Other Incentives And Sales Returns
RevenueRecognitionProvisionForDiscountsChargeBacksFeesRebatesOtherIncentivesAndSalesReturns
14452000
CY2020 kpti Revenue Recognition Payments For Fees Rebates And Other Incentives Current Year
RevenueRecognitionPaymentsForFeesRebatesAndOtherIncentivesCurrentYear
-3889000
CY2020 kpti Revenue Recognition Credits For Discounts Charge Backs Fees Rebates Other Incentives And Sales Returns Current Year
RevenueRecognitionCreditsForDiscountsChargeBacksFeesRebatesOtherIncentivesAndSalesReturnsCurrentYear
-12566000
CY2020Q4 kpti Revenue Recognition Discounts And Charge Backs
RevenueRecognitionDiscountsAndChargeBacks
2079000
CY2020Q4 kpti Revenue Recognition Fees Rebates And Other Incentives
RevenueRecognitionFeesRebatesAndOtherIncentives
2193000
CY2020Q4 kpti Revenue Recognition Sales Return
RevenueRecognitionSalesReturn
669000
CY2020Q4 kpti Revenue Recognition Discounts Charge Backs Fees Rebates Other Incentives And Sales Returns
RevenueRecognitionDiscountsChargeBacksFeesRebatesOtherIncentivesAndSalesReturns
4941000
CY2021 kpti Revenue Recognition Provision For Discounts And Charge Backs
RevenueRecognitionProvisionForDiscountsAndChargeBacks
13546000
CY2021 kpti Revenue Recognition Provision For Fees Rebates And Other Incentives
RevenueRecognitionProvisionForFeesRebatesAndOtherIncentives
7849000
CY2021 kpti Revenue Recognition Sale Returns Reserve For Sale Returns
RevenueRecognitionSaleReturnsReserveForSaleReturns
-235000
CY2021 kpti Revenue Recognition Provision For Discounts Charge Backs Fees Rebates Other Incentives And Sales Returns
RevenueRecognitionProvisionForDiscountsChargeBacksFeesRebatesOtherIncentivesAndSalesReturns
21160000
CY2021 kpti Revenue Recognition Payments For Chargebacks Current Year
RevenueRecognitionPaymentsForChargebacksCurrentYear
-13714000
CY2021 kpti Revenue Recognition Payments For Fees Rebates And Other Incentives Current Year
RevenueRecognitionPaymentsForFeesRebatesAndOtherIncentivesCurrentYear
-7736000
CY2021 kpti Revenue Recognition Payments For Discounts Charge Backs Fees Rebates Other Incentives And Sales Returns
RevenueRecognitionPaymentsForDiscountsChargeBacksFeesRebatesOtherIncentivesAndSalesReturns
-90000
CY2021 kpti Revenue Recognition Credits For Discounts Charge Backs Fees Rebates Other Incentives And Sales Returns Current Year
RevenueRecognitionCreditsForDiscountsChargeBacksFeesRebatesOtherIncentivesAndSalesReturnsCurrentYear
-21540000
CY2021Q4 kpti Revenue Recognition Discounts And Charge Backs
RevenueRecognitionDiscountsAndChargeBacks
1911000
CY2021Q4 kpti Revenue Recognition Fees Rebates And Other Incentives
RevenueRecognitionFeesRebatesAndOtherIncentives
2306000
CY2021Q4 kpti Revenue Recognition Sales Return
RevenueRecognitionSalesReturn
344000
CY2021Q4 kpti Revenue Recognition Discounts Charge Backs Fees Rebates Other Incentives And Sales Returns
RevenueRecognitionDiscountsChargeBacksFeesRebatesOtherIncentivesAndSalesReturns
4561000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
20000000.0
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12900000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2020 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1300000
CY2021Q3 kpti Additional Common Share Issued On Assets Acquired
AdditionalCommonShareIssuedOnAssetsAcquired
75000000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29783000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24407000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15291000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29783000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24407000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15291000
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2900000
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2900000
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1700000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-37088000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-23350000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-93768000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-158876000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-176200000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-30052000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-123820000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-195964000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-199550000
CY2021Q4 kpti Deferred Tax Assets Operating Loss Carryforwards Domestic And State And Local
DeferredTaxAssetsOperatingLossCarryforwardsDomesticAndStateAndLocal
187762000
CY2020Q4 kpti Deferred Tax Assets Operating Loss Carryforwards Domestic And State And Local
DeferredTaxAssetsOperatingLossCarryforwardsDomesticAndStateAndLocal
179462000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
88091000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
75189000
CY2021Q4 kpti Deferred Tax Assets Fixed Assets And Intangibles
DeferredTaxAssetsFixedAssetsAndIntangibles
28268000
CY2020Q4 kpti Deferred Tax Assets Fixed Assets And Intangibles
DeferredTaxAssetsFixedAssetsAndIntangibles
9602000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
12555000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
13814000
CY2021Q4 kpti Deferred Tax Assets Tax Deferred Expense Reserves And Accruals And Other Temporary Differences
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAndOtherTemporaryDifferences
5964000
CY2020Q4 kpti Deferred Tax Assets Tax Deferred Expense Reserves And Accruals And Other Temporary Differences
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAndOtherTemporaryDifferences
4970000
CY2021Q4 kpti Deferred Tax Assets Interest Expense
DeferredTaxAssetsInterestExpense
3704000
CY2020Q4 kpti Deferred Tax Assets Interest Expense
DeferredTaxAssetsInterestExpense
1321000
CY2021Q4 kpti Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
2676000
CY2020Q4 kpti Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
3084000
CY2021Q4 kpti Deferred Tax Assets Ahydo Interest
DeferredTaxAssetsAhydoInterest
2069000
CY2020Q4 kpti Deferred Tax Assets Ahydo Interest
DeferredTaxAssetsAhydoInterest
1017000
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
388000
CY2020Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
708000
CY2021Q4 kpti Deferred Tax Assets Royalty Embaded Derivatives
DeferredTaxAssetsRoyaltyEmbadedDerivatives
720000
CY2020Q4 kpti Deferred Tax Assets Royalty Embaded Derivatives
DeferredTaxAssetsRoyaltyEmbadedDerivatives
421000
CY2021Q4 kpti Deferred Tax Assets Unicap
DeferredTaxAssetsUnicap
903000
CY2020Q4 kpti Deferred Tax Assets Unicap
DeferredTaxAssetsUnicap
190000
CY2020Q4 kpti Deferred Tax Assets Transaction Costs
DeferredTaxAssetsTransactionCosts
92000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
330902000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
275389000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2198000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14481000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0
CY2021 kpti Fair Market Value Of The Rights Upfront Payment
FairMarketValueOfTheRightsUpfrontPayment
75000000.0
CY2021Q4 kpti Deferred Tax Liabilities Convertible Debt Amortization
DeferredTaxLiabilitiesConvertibleDebtAmortization
-6000
CY2020Q4 kpti Deferred Tax Liabilities Convertible Debt Amortization
DeferredTaxLiabilitiesConvertibleDebtAmortization
11825000
CY2021Q4 kpti Deferred Tax Assets Right Of Use Asset
DeferredTaxAssetsRightOfUseAsset
-1849000
CY2020Q4 kpti Deferred Tax Assets Right Of Use Asset
DeferredTaxAssetsRightOfUseAsset
2188000
CY2021Q4 kpti Deferred Tax Assets Deferred Royalty Obligation
DeferredTaxAssetsDeferredRoyaltyObligation
-343000
CY2020Q4 kpti Deferred Tax Assets Deferred Royalty Obligation
DeferredTaxAssetsDeferredRoyaltyObligation
468000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2198000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
14481000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
55500000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.008
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.016
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.017
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.027
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.010
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.113
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.065
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.060
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.052
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.041
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.025
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.354
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.257
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.259
CY2021 kpti Effective Income Tax Rate Reconciliation At Migrated Intellectual Property Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationAtMigratedIntellectualPropertyIncomeTaxRatePercent
0.139
CY2020 kpti Effective Income Tax Rate Reconciliation At Migrated Intellectual Property Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationAtMigratedIntellectualPropertyIncomeTaxRatePercent
0.021
CY2019 kpti Effective Income Tax Rate Reconciliation At Migrated Intellectual Property Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationAtMigratedIntellectualPropertyIncomeTaxRatePercent
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.043
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.006
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.005
CY2020 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.003
CY2019 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.006
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.009
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2020Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
1800000
CY2021 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
100000
CY2021 kpti Operating Loss And Tax Credit Carryforwards Limitations Period Over Which Cumulative Changes In Ownership Interest Of Significant Shareholders Considered
OperatingLossAndTaxCreditCarryforwardsLimitationsPeriodOverWhichCumulativeChangesInOwnershipInterestOfSignificantShareholdersConsidered
P3Y
CY2021 kpti Operating Loss And Tax Credit Carryforwards Limitations Threshold Percentage Of Cumulative Changes In Ownership Interest Of Significant Shareholders Considered
OperatingLossAndTaxCreditCarryforwardsLimitationsThresholdPercentageOfCumulativeChangesInOwnershipInterestOfSignificantShareholdersConsidered
50
CY2021 kpti Debt Instrument Convertible Threshold Measurement Period Description
DebtInstrumentConvertibleThresholdMeasurementPeriodDescription
during the five-business day period immediately after any five consecutive trading day period
CY2021 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
5
CY2021 kpti Principal Amount Of Notes Used In Conversion Rate
PrincipalAmountOfNotesUsedInConversionRate
1000
CY2021 kpti Debt Instrument Convertible Threshold Maximum Percentage Of Product Of Last Reported Sale Price Of Common Stock
DebtInstrumentConvertibleThresholdMaximumPercentageOfProductOfLastReportedSalePriceOfCommonStock
0.98
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5175000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5175000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5175000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
177675000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
193200000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
23907000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
169293000
CY2021Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
3100000
CY2020 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
500000

Files In Submission

Name View Source Status
0000950170-22-002548-index-headers.html Edgar Link pending
0000950170-22-002548-index.html Edgar Link pending
0000950170-22-002548.txt Edgar Link pending
0000950170-22-002548-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img92647567_0.jpg Edgar Link pending
img92647567_1.jpg Edgar Link pending
img92647567_2.jpg Edgar Link pending
kpti-20211231.htm Edgar Link pending
kpti-20211231.xsd Edgar Link pending
kpti-20211231_cal.xml Edgar Link unprocessable
kpti-20211231_def.xml Edgar Link unprocessable
kpti-20211231_htm.xml Edgar Link completed
kpti-20211231_lab.xml Edgar Link unprocessable
kpti-20211231_pre.xml Edgar Link unprocessable
kpti-ex10_11.htm Edgar Link pending
kpti-ex10_17.htm Edgar Link pending
kpti-ex10_18.htm Edgar Link pending
kpti-ex10_19.htm Edgar Link pending
kpti-ex10_41.htm Edgar Link pending
kpti-ex21_1.htm Edgar Link pending
kpti-ex23_1.htm Edgar Link pending
kpti-ex31_1.htm Edgar Link pending
kpti-ex31_2.htm Edgar Link pending
kpti-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending